BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Thursday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Down 4.2 %

Shares of BIOL stock opened at $0.01 on Thursday. The firm has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.02. The company has a market capitalization of $237,189.70, a PE ratio of 0.00 and a beta of 0.67. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.